期刊文献+

PICK-1蛋白在多种肿瘤中的表达及在乳腺癌的临床意义 被引量:1

The Expression of PICK-1 Protein in Breast Cancer and Its Significance
下载PDF
导出
摘要 目的:主要探讨乳腺浸润性癌组织中PICK-1蛋白的表达与该肿瘤临床病理、其他生物学指标以及患者预后的相关性。方法:采用组织芯片免疫组织化学染色方法检测496例乳腺浸润性癌组织中PICK-1、ER、PR、HER2/neu、TlMP-1等蛋白的表达情况及表达间的相关性,以及PICK-1蛋白在不同分子亚型乳腺癌中的表达情况及对预后的影响。结果:PICK-1蛋白在乳腺癌组织中的表达率为27.22%,肿瘤细胞中PICK-1的高表达与淋巴结受累和高组织学分级相关(P均<0.001),且与HER2/neu表达相关(P<0.001),而与雌孕激素受体状态无关(P>0.05),同时该蛋白的表达与TIMP-1表达呈正相关(P=0.002)。PICK-1蛋白表达与患者总生存期缩短相关,分层分析显示PICK-1仅对淋巴结阳性患者的预后有影响,同时对HER2/neu不同状态患者的影响不同,其中对三阴性乳腺癌(HR-HER-)预后影响最大。单因素分析显示乳腺肿瘤直径、组织学分级、淋巴结状态、HR状态、HER2/neu表达、TIMP-1表达、肿瘤细胞表达PICK-1均是有意义的预后指标;但多因素分析显示仅肿瘤直径、组织学分级、淋巴结状态、HER2/neu袁达和PICK-1表达是独立的预后因素。结论:PICK-1蛋白与浸润性乳腺癌的侵袭和转移特性相关,同时有可能作为患者预后不良的指标,尤其是对于三阴性乳腺癌的预后意义更为显著。 Objective: To investigate the expression of PICK-1 protein in invasive breast carcinoma and to determine its relationship with the clinicopathologic features, other biological indicators, and prognosis. Methods: We used immunohistochemistry to detect the expressions of PICK-1, estrogen receptor, progesterone receptor, HER2/neu, and TIMP-1 in paraffin-embedded tissue microarrays from 496 cases of invasive breast carcinoma. Results: PICK-1 protein was detected in the cytoplasm of malignant cells in 27.22% cases. High expression of PICK-1 protein within cancer cells was associated with lymph node infiltration and higher grade (P〈0.001) and was positively correlated with HER2/neu expression (P〈0.001). High expression of PICK-1 protein was also associated with expression of TIMP-1 (P=0.002). Moreover, high expression of PICK-1 was associated with short overall survival and subsets of positive lymph node. Tumor-derived PICK-1 has different impact on patients with different HER2/neu status, especially for HR-HER-type. Univariate survival analysis showed that tumor size, grade, lymph node status, HR status, HER2/neu expression, TIMP-1 expression, and PICK-1 expression were prognostic factors. Multivariate survival analysis showed that tumor size, grade, lymph node status, HER2/neu expression, and PICK-1 expression were independent prognostic factors. Conclusion: PICK-1 protein is correlated with an invasive and metastatic tumor phenotype and may be used as a prognostic marker of breast carcinoma.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2009年第7期397-403,共7页 Chinese Journal of Clinical Oncology
基金 天津市卫生局科技基金项目资助(编号:05KY33)
关键词 PICK-1 乳腺浸润性癌 组织芯片 预后HER2/neu PICK-1 Invasive breast cancer Tissue microarray Prognosis HER2/neu
  • 相关文献

参考文献19

  • 1Lin WJ, Chang YF, Wang WL, et al. Mitogen-stimulated TIS21 protein interacts with a protein-kinase-Calpha-binding protein rPICK1[J].Biochem J, 2001, 354 (Pt 3): 635-643.
  • 2Torres GE, Yao WD, Mohn AR, et al. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1[J].Neuron, 2001, 30 (1): 121-134.
  • 3Jaulin--Bastard F, Saito H, Le Bivic A, et al. The ERBB2/HER2 receptor differentially interacts with ERBIN and PICK1 PSD-95/ DLG/ZO-1 domain proteins[J].J Biol Chem, 2001, 276(18): 15256-15263.
  • 4Excoffon KJ, Hruska-Hageman A, Klotz M, et al. A role for the PDZ-binding domain of the coxsackie B virus and adenovirus receptor (CAR) in cell adhesion and growth[J].J Cell Sci, 2004,117 (Pt 19): 4401-4409.
  • 5Jones SR, Gainetdinov RR, Jaber M, et al. Profound neuronal plasticity in response to inactivation of the dopamine transporter[J].Proc Nad Acad Sci U S A, 1998, 95(7): 4029-4034.
  • 6Duggan A, Garcia-AnoverosJ, Corey DP. The PDZ domain protein PICK1 and the sodium channel BNaC1 interact and localize at mechanosensory terminals of dorsal root ganglion neurons and dendrites of central neurons[J]. J Biol Chem, 2002, 277(7): 5203-5208.
  • 7<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 8Hirbec H, Francis JC, Lauri SE, et al. Rapid and differential regulation of AMPA and kainate receptors at hippocampal mossy fibre synapses by PICK1 and GRIP[J]. Neuron, 2003, 37(4): 625-638.
  • 9Lin SH, Arai AC, Wang Z, et al. The carboxyl terminus of the prolactin-releasing peptide receptor interacts with PDZ domain proteins involved in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor clustering[J]. Mol Pharmacol, 2001, 60(5): 916-923.
  • 10Penzes P, Beeser A, Chernoff J, et al. Rapid induction of dendritic spine morphogenesis by trans-synaptic ephrinB-EphB receptor activation of the Rho-GEF kalirin[J]. Neuron, 2003, 37(2): 263-274.

二级参考文献10

  • 1Watters AD,Going JJ,Cooke GT,et al.Chromosome 17 aneusomy is associated with poor prognostic factors in invesive breast carcinoma.Breast Cancer Res Treat,2003,77:109-114.
  • 2Bilous M,Morey A,Armes J,et al.Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry.Pathology,2006,38:120-124.
  • 3Goldhirsch A,Glick JH,Gelber RD,et al.Meeting highlights:international expert consensus on the primary therapy of early breast cancer 2005.Annals Oncol,2005,16:1569-1583.
  • 4The Center For Devices and Radiological Health (CDRH) of the Food and Drug Administration.A document of evaluation about the PathVysionTM HER-2 DNA Probe Kit of Vysis,INC.for detecting amplification of the HER-2/neu gene via fluorescence in situ hybridization (FISH) in formalin-fixed,paraffin-embedded human breast cancer tissue specimens.[2001-12-31].http://www.fda.gov/cdrh/pmapage.html.
  • 5Shak S.Overview of the trastuzumab (Hereeptin) anti-HER2monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer.Herceptin Multinational Investigator Study Group.Semin Oncol,1999,26(4 Suppl 12):71-77.
  • 6Hammock L,Lewis M,Philips,C,et al.Strong HER-2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization.Hum Pathol,2003,34:1043-1047.
  • 7北京市发展和改革委员会.关于公布荧光原位杂交基因检测(FISH)等新增医疗服务价格项目的通知.京发改[2006]1376号.http://www.bjpc.gov.cn/tztg/200608/t129145.btm.
  • 8Hicks DG,Tubbs RR.Assessment of the Her2 status in breast cancer by fluorescence in situ hybridization:a technical review with interpretive guidelines.Hum Pathol,2005,36:250-261.
  • 9Wang S,Hossein Saboorian H,Frenkel EP,et al.Aneusomy 17 in breast cancer:its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status.Mod Pathol,2002,15:137-145.
  • 10Risio M,Casorzo L,Redana S,et al.HER2 gene-amplified breast cancers with monosomy of chromosome 17 are poorly responsive to trastuzumab-based treatment.Oncol Rep,2005,13:305-309.

共引文献163

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部